Krsnaa Diagnostics Q2 Results FY27 Preview: Results Date, Preview and Expectations for Investors

Track the latest Krsnaa Diagnostics Ltd. share price on Univest. This is a point investors are watching closely around Krsnaa Diagnostics Q2 results. This is a point investors are watching closely around Krsnaa Diagnostics Q2 results.

The Krsnaa Diagnostics Q2 results for the September 2026 quarter are on investor radars as the diagnostics chain approaches another earnings season. This Krsnaa Diagnostics Q2 results preview builds on the company's actual reported numbers from the past five quarters and highlights the trends and factors worth watching, rather than forecasting any specific revenue or profit figure. It remains a relevant data point for Krsnaa Diagnostics Q2 results watchers. It remains a relevant data point for Krsnaa Diagnostics Q2 results watchers.

Open a free demat account with Univest

Krsnaa Diagnostics Q2 Results Date: When Will It Be Announced?

The Krsnaa Diagnostics q2 results date for the September 2026 quarter has not been officially announced yet. Based on the company's historical results calendar pattern, Q2 FY27 results are typically expected in the second half of October or early November 2026. Investors searching for the Krsnaa Diagnostics q2 results date should track exchange filings on NSE and BSE as the quarter end approaches. Analysts tracking Krsnaa Diagnostics Q2 results will note this trend. Analysts tracking Krsnaa Diagnostics Q2 results will note this trend.

Until the company issues an official board meeting intimation, no specific date should be treated as confirmed. This detail is part of the broader Krsnaa Diagnostics Q2 results discussion this quarter. This detail is part of the broader Krsnaa Diagnostics Q2 results discussion this quarter.

Krsnaa Diagnostics Q2 Results Expectations: What to Track

Also read – Gabriel India Q2 Results FY27 Preview

This q2 results preview section focuses on trend and context rather than a specific number. The most important thing to understand while forming q2 results expectations for Krsnaa Diagnostics is the composition of net profit in the most recent quarters. The March 2026 quarter saw net profit jump to Rs 42 crore largely because of a sharp increase in Other Income to around Rs 32 crore, according to available screener data. This appears to be a one off or non operating item rather than a sign of core operating strength, and investors will want to separate operating profit trends from such items when reading the Q2 FY27 results. It is one more data point relevant to Krsnaa Diagnostics Q2 results.

On the operating side, revenue and operating profit margin (OPM) trends will matter more than the headline net profit number. Investors will likely watch whether OPM can hold in the 24 to 29 percent range seen over the last five quarters, and whether Other Income normalises back to levels seen before the Mar26 spike. This adds useful context to Krsnaa Diagnostics Q2 results for investors.

Start investing today with a free Univest demat account

Krsnaa Diagnostics Q1 FY27 (June 2026 Quarter) Performance

In the June 2026 quarter, Krsnaa Diagnostics reported revenue of Rs 236 crore, the highest in the trailing five quarter window, with an operating profit of Rs 58 crore, an operating profit margin of 24.58 percent, and net profit of Rs 17 crore. Note that the net profit figure here is meaningfully lower than the Mar26 quarter's Rs 42 crore, precisely because the Mar26 number was inflated by the one off Other Income item discussed above and Jun26 does not carry that same boost. Market watchers following Krsnaa Diagnostics Q2 results will keep this in view.

This makes Jun26 a cleaner base for assessing core operating momentum than the preceding Mar26 quarter. This remains relevant background for Krsnaa Diagnostics Q2 results.

Krsnaa Diagnostics Q2 FY26 (September 2025 Quarter): The YoY Base

The September 2025 quarter, which is the base for the upcoming year on year comparison, saw Krsnaa Diagnostics post revenue of Rs 206 crore, operating profit of Rs 59 crore, an operating profit margin of 28.64 percent, and net profit of Rs 24 crore. This was actually the strongest margin quarter across the entire five quarter data set. It is worth noting in the context of Krsnaa Diagnostics Q2 results.

With Q2 FY26 carrying a relatively high 28.64 percent OPM, the upcoming Q2 FY27 results will need either meaningfully higher revenue or a similarly strong margin for operating profit to show healthy year on year growth. This is part of the broader picture around Krsnaa Diagnostics Q2 results.

Recent Quarterly Trend: Jun25 to Jun26

The full quarterly run shows a business with a generally rising revenue base but a fluctuating margin profile. Revenue moved from Rs 193 crore in Jun25 to Rs 206 crore in Sep25, dipped to Rs 181 crore in Dec25, recovered to Rs 193 crore in Mar26, and climbed to Rs 236 crore in Jun26. Operating profit margin ranged from a low of 25.41 percent in Dec25 to a high of 28.64 percent in Sep25, before settling at 24.58 percent in Jun26, the lowest OPM print in the window. Investors tracking Krsnaa Diagnostics Q2 results may find this useful context.

Net profit tells a more distorted story because of the Mar26 Other Income spike: it moved from Rs 21 crore in Jun25 to Rs 24 crore in Sep25, fell to Rs 15 crore in Dec25, then jumped to Rs 42 crore in Mar26 before falling back to Rs 17 crore in Jun26. Reading net profit trend alone without adjusting for the Mar26 anomaly would give a misleading picture of the underlying business. This adds to the overall picture for Krsnaa Diagnostics Q2 results.

Also read – Gala Precision Engineering Q2 Results FY27 Preview

Key Factors to Watch This Quarter

Ahead of the Krsnaa Diagnostics q2 results FY27 for the September 2026 quarter, the operating profit margin trend is the single most important factor to watch, given that Jun26's 24.58 percent OPM was the lowest in the trailing five quarters. Investors will watch whether this was a one quarter dip or the start of a margin compression trend.

The scale and consistency of diagnostic testing volumes across the company's public private partnership contracts, along with any update on new contract wins or renewals, will also be relevant factors to watch as the quarter unfolds.

Open your free demat account on Univest now

Krsnaa Diagnostics Valuation Snapshot

At the current market price of Rs 535.55, Krsnaa Diagnostics trades at a price to earnings (PE) ratio of 17.85 times and a price to book (PB) ratio of 1.77 times, against a book value of Rs 302.00 per share. Trailing EPS stands at Rs 30.00, and return on equity (ROE) is 10.9 percent, with a debt to equity (D/E) ratio of 0.54.

The stock offers a dividend yield of 0.34 percent. On the 52 week range, the stock has moved between a low of Rs 515.00 and a high of Rs 894.40, and the current price sits below both the 50 day moving average of Rs 559.35 and the 200 day moving average of Rs 690.25. The RSI reading of 37.6 suggests the stock is closer to oversold territory. Market capitalisation is approximately Rs 1,737 crore.

What to Watch in Q2 FY27

As the q2 results 2026 season approaches, investors should track whether operating margin recovers from the Jun26 low, whether Other Income normalises after the Mar26 spike, and how revenue growth compares against both the Sep25 base and the Jun26 print. This q2 results preview is meant to frame these questions using the company's own reported numbers.

Conclusion: Krsnaa Diagnostics Q2 Results FY27 in Perspective

This Krsnaa Diagnostics q2 results preview has laid out the actual quarterly trend from June 2025 through June 2026, flagged the one off nature of the Mar26 Other Income spike, and summarised current valuation metrics, without forecasting any specific number for the September 2026 quarter. Investors should wait for the official results announcement before drawing conclusions, and this content should not be treated as investment advice.

When will Krsnaa Diagnostics announce its Q2 FY27 results?

Ans. The exact Krsnaa Diagnostics q2 results date has not been officially announced yet. Based on the company's historical results calendar pattern, the announcement is typically expected in the second half of October or early November 2026.

Why was Krsnaa Diagnostics net profit so high in March 2026?

Ans. The March 2026 quarter saw net profit rise to Rs 42 crore largely due to a sharp increase in Other Income of around Rs 32 crore, which appears to be a one off or non operating item rather than a sign of core operating strength.

What was Krsnaa Diagnostics revenue in Q1 FY27?

Ans. In the June 2026 quarter, Krsnaa Diagnostics reported revenue of Rs 236 crore, an operating profit margin of 24.58 percent, and net profit of Rs 17 crore.

What is the current valuation of Krsnaa Diagnostics shares?

Ans. Krsnaa Diagnostics trades at a PE ratio of 17.85 times and a PB ratio of 1.77 times as of the current market price of Rs 535.55, with a return on equity of 10.9 percent.